Savvy Updates 10/7/24: Somatostatin Protects Against Sudden BG Drops, Sernova’s Cell Pouch, A Spoonful of Laughter
It was a quiet week for diabetes news, in this issue of The Savvy Diabetic: Somatostatin May Protect Against Sudden BG Drops Sernova’s Cell Pouch Contains Vascularized, Functioning Islets > 5 years A Spoonful of Laughter for dStimatize.org (diaTribe)...
Savvy Updates, 8/5/24: Tandem Mobi Expansion Plans, T1D Vision/Hearing Loss Need Access to D Tech, More on Dexcom & Geofencing, Spotlight on Creativity: Krista Sheneman
Tandem CMO shares Mobi feedback, expansion plans by Elise Reuter for MedTechDive.com, 29 July 2024. Tandem Diabetes Care this year began a full launch of its smallest insulin pump, called Mobi, after the device received clearance from the Food and Drug Administration...
Savvy Updates 7/29/24: Abbott FS Libre 3 Sensors Warning, Dexcom Stock Plummets, T1Ds Fear GLP-1s Will Edge Out Insulin, Sleep Apnea & Retinopathy, Diamyd Fast-Tracked, Shuren Leaves FDA CDRH, T1D Moonshot Robert Oringer, Embecta Considers Sale, SmartStart’s Interactive Educational Platform
Abbott Issues Warning for Certain FreeStyle Libre 3 Sensors by Paul Heltzel for diaTribe.org, 25 July 2024. Some FreeStyle Libre 3 continuous glucose monitoring sensors could display false high readings and should be immediately discontinued, urged the manufacturer....
Savvy Updates 7/22/24: ALERT: Dexcom G7 & Geofencing, Sensulin Glucose-Responsive Insulin, Bulsai Infrared Sensor for Placing for Insulin Injections, iAPS/Trio DIY Insulin Algorithm, Replica Health Personalized Metabolic Healthcare, Free Lifetime US National Parks Pass
Dexcom G7 & Geofencing: Travel Alert If you are a Dexcom G7 user or using MDI with connection to phone app, PLEASE READ: you are planning travel shortly away from your home country, and you use open-source DIY app or MDI or Mobi or will use O5 with G7 Dexcom G7 is...
Savvy Updates 7/15/24: Novo Icodec Rejected by FDA, Is Stevia Safe?, Sucrolose & Environment, BG Changes Impact Cognitive Function, Ypsomed Pump, Islet Cell Replacement Therapy, FTC to Sue 3 Largest PBMs, GO-Pen Creates Equal Access, Medicare Cuts Physician Pay
Novo’s once-weekly insulin rejected by FDA by Kristin Jensen for BioPharmaDive.com, 11 July 2024. Novo is one of the world’s premier manufacturers, along with Indianapolis-based Eli Lilly. Both have been working for years to offer patients a more convenient option...
More Diabetes Blogs